|
Market Closed -
Nasdaq
04:00:00 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 124.37 USD | -2.64% |
|
-2.69% | +25.92% |
| 08-29 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| 08-28 | Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil | MT |
| Market Cap | 25.21B 21.72B 20.37B 18.59B 35.03B 2,409B 35.14B 242B 94.28B 1,216B 94.65B 92.59B 4,033B | P/E 2026 * |
55.5x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 20.98B 18.08B 16.95B 15.47B 29.15B 2,005B 29.24B 201B 78.46B 1,012B 78.77B 77.05B 3,356B | EV / Sales 2026 * |
3.53x | EV / Sales 2027 * | 3.07x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Incyte Corporation
| 1 day | -2.64% | ||
| 1 week | -2.69% | ||
| Current month | +4.06% | ||
| 1 month | +1.12% | ||
| 3 months | +28.56% | ||
| 6 months | +24.32% | ||
| Current year | +25.92% |
| 1 week | 123.08 |  | 130.8 |
| 1 month | 115.77 | | 130.8 |
| Current year | 89.25 | | 132.6 |
| 1 year | 81.09 | | 132.6 |
| 3 years | 50.27 | | 132.6 |
| 5 years | 50.27 | | 132.6 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 04/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/8/26 | Tax | EVP, Human Resources | -504 | 0.0002% | ||
| 19/8/26 | Sell | Chairperson | -10,801 | 0.0053% | ||
| 12/8/26 | Sell | Chairperson | -10,803 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.64% | -2.69% | +46.99% | +90.61% | 25.21B | |
| -1.67% | -4.78% | +36.76% | -4.88% | 79.3B | |
| -0.44% | +1.45% | -18.40% | -37.28% | 59.21B | |
| -3.35% | -4.92% | +472.81% | +18.32% | 55.09B | |
| -6.78% | -4.19% | -3.45% | +28.01% | 49.86B | |
| -0.60% | -2.18% | +8.03% | +159.90% | 47.9B | |
| -1.35% | +0.79% | +65.25% | -18.22% | 32.28B | |
| -3.44% | +4.32% | -1.52% | +195.73% | 23.87B | |
| -3.15% | -0.04% | +59.65% | +113.52% | 16.89B | |
| +2.73% | 0.00% | -5.13% | +809.29% | 16.17B | |
| Average | -1.99% | -1.09% | +66.10% | +135.50% | 40.58B | |
| Weighted average by Cap. | -2.14% | -1.97% | +79.51% | +71.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.94B 5.12B 4.8B 4.38B 8.26B 568B 8.28B 56.96B 22.22B 287B 22.31B 21.82B 951B | 6.27B 5.4B 5.06B 4.62B 8.7B 599B 8.73B 60.05B 23.43B 302B 23.52B 23.01B 1,002B |
| Net income | 466M 401M 376M 344M 647M 44.52B 649M 4.47B 1.74B 22.47B 1.75B 1.71B 74.52B | 1.5B 1.29B 1.21B 1.1B 2.08B 143B 2.08B 14.34B 5.59B 72.17B 5.62B 5.49B 239B |
| Net Debt | -4.23B -3.64B -3.42B -3.12B -5.88B -404B -5.9B -40.54B -15.82B -204B -15.88B -15.53B -677B | -5.99B -5.16B -4.84B -4.42B -8.32B -573B -8.35B -57.43B -22.41B -289B -22.49B -22B -958B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$124.37 | -2.64% | 1,215,069 |
| 27/08/26 | US$127.74 | -0.30% | 700,682 |
| 26/08/26 | US$128.12 | -1.23% | 800,283 |
| 25/08/26 | US$129.72 | +1.36% | 1,162,238 |
| 24/08/26 | US$127.98 | +0.13% | 799,608 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
